Category: news

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Dicerna™ Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi)…

KENILWORTH, N.J.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24MRK&src=ctag" target="_blank"gt;$MRKlt;/agt; lt;a href="https://twitter.com/hashtag/MRK?src=hash" target="_blank"gt;#MRKlt;/agt;–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today…

WATERTOWN, Mass.–(BUSINESS WIRE)–Lyra Therapeutics, Inc., a clinical-stage biotechnology company developing medicines precisely designed to target ear, nose and throat (ENT)…

LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/CancerTherapeutics?src=hash" target="_blank"gt;#CancerTherapeuticslt;/agt;–The global throat cancer therapeutics market is expected to post a CAGR of close to 7% during…

DUBLIN–(BUSINESS WIRE)–The “Global Eye Allergy Therapeutics Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering. This is expected to propel…

DUBLIN–(BUSINESS WIRE)–The “Global Attention deficit Hyperactivity Disorder (ADHD) Drugs Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering. The attention…

JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of a generic version of Ranexa®1 (ranolazine)…

Approval marks the first chemotherapy-free combination regimen for patients who have relapsed or did not respond to previous treatment Approval…

– Confirmation of VALBIOTIS’s capacity to produce VALEDIA® in compliance with North American and European industrial standards. – A key…

LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Analytics?src=hash" target="_blank"gt;#Analyticslt;/agt;–A global data analytics and advisory firm, Quantzig, that delivers actionable analytics solutions to resolve complex business…